The FDA has issued a report assembled by the inter-agency Drug Shortages Task Force to determine the root causes of drug shortages, and to offer recommendations based on the insights from stakeholders in the private and public sectors to help prevent future drug shortages.
Potentially inappropriate prescribing tied to ED visits, adverse drug events, functional decline.
Regulations will require companies to disclose prices of meds costing more than $35 for a month’s supply
Differences found in reaction symptoms and types of drugs tied to adverse reactions
Pharmacy closures appear to impact cardiovascular medication adherence among older patients, according to findings from a retrospective cohort study published in JAMA Network Open.
Frequent medication shortages have led to various allocation and rationing methods by pharmacy practice managers and/or pharmacy leaders (PPMs), according to results of a survey published in JAMA Internal Medicine.
The companies involved in these mergers say they will improve coordination of care for consumers, but critics say consumers could be left with far fewer choices and potentially higher costs.
Two differences were identified: the use of a dosage schedule, which was more frequent in studies published in 2011 or before and in studies outside the United States, and the teach-back technique, which was used more frequently in the United States.
According to the results of the survey, 64% of respondents reported waiting at least one business day for a PA decision from health plans, with 30% waiting at least three business days.
The researchers found that during the 3-year study period, about 98 million outpatient antibiotic prescriptions were filled by 39 million insurance beneficiaries. Azithromycin, amoxicillin, amoxicillin/clavulanate, ciprofloxacin, and cephalexin were the most commonly prescribed antibiotics.
